... WhatsApp

New Hepatitis C Medicines Improve Survival After Liver Cancer Surgery

You are here >> Home > Latest Updates > Liver Cancer Updates > New Hepatitis…

New Hepatitis C Medicines Improve Survival After Liver Cancer Surgery

People with hepatitis C are at higher risk of liver cancer. Surgery can remove part of the liver, but cancer often comes back. A new international study looked at how modern hepatitis C medicines, called direct-acting antivirals (DAAs), affect survival after liver cancer surgery.

The study included 738 patients from 7 hospitals around the world. Some patients received DAAs before surgery, some received older treatments, and some had no treatment for hepatitis C. Researchers followed patients for over 7 years.

The results showed that people who took DAAs lived longer after surgery. They also had a lower chance of their liver cancer coming back. Patients on DAAs had a much higher rate of clearing the virus (92%) compared with older treatments (71%). Importantly, taking DAAs before surgery did not increase the risk of serious complications in the first 90 days after surgery.

This means DAAs not only control hepatitis C but also improve outcomes for people with liver cancer. For patients facing surgery, these medicines may provide hope for a better recovery and longer life.

If you or someone you know has hepatitis C and liver cancer, it is worth asking your doctor about DAAs. They could make a real difference in both cancer outcomes and overall health.

Rate this post
Dr. Harsh J Shah

Exclusive Health Tips and Updates

Dr Harsh Shah - GI & HPB Oncosurgeon in India
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.